BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xu LN, Zou SQ, Wang JM. Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma. World J Gastroenterol 2005; 11(24): 3719-3723 [PMID: 15968727 DOI: 10.3748/wjg.v11.i24.3719]
URL: https://www.wjgnet.com/1007-9327/full/v11/i24/3719.htm
Number Citing Articles
1
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 2647 doi: 10.1007/978-3-319-26956-6_148
2
Jie Chu, Wei Liu, Xinyue Hu, Huiling Zhang, Jiudong Jiang. P2RY13 is a prognostic biomarker and associated with immune infiltrates in renal clear cell carcinoma: A comprehensive bioinformatic studyHealth Science Reports 2023; 6(12) doi: 10.1002/hsr2.1646
3
Sanjeev K. Maurya, Mallika Tewari, Raghvendra R. Mishra, Hari S. Shukla. Genetic abberations in gallbladder cancerSurgical Oncology 2012; 21(1): 37 doi: 10.1016/j.suronc.2010.09.003
4
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_148-1
5
Rajani Rai, Kiran L. Sharma, Surbhi Sharma, Sanjeev Misra, Ashok Kumar, Balraj Mittal, Masaru Katoh. Death Receptor (DR4) Haplotypes Are Associated with Increased Susceptibility of Gallbladder Carcinoma in North Indian PopulationPLoS ONE 2014; 9(2): e90264 doi: 10.1371/journal.pone.0090264
6
Juan Carlos Roa, N. Volkan Adsay. Molecular Surgical Pathology2013; : 65 doi: 10.1007/978-1-4614-4900-3_4
7
Gururao Hariprasad, Roopa Hariprasad, Lalit Kumar, Alagiri Srinivasan, Srujana Kola, Amit Kaushik. Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancersBiomarkers 2013; 18(6): 532 doi: 10.3109/1354750X.2013.822561